CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended		156 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014
Cash flows from operating activities:
Income (loss) for the period	$ 3,755,438	$ (2,620,060)	$ (21,331,241)
Adjustments to reconcile income (loss) for the period to net cash used in operating activities:
Depreciation	26,091	23,461	217,808
Increase (decrease) in liability for employee rights upon retirement		(3,141)	196,506
Stock-based compensation	19,854	18,792	1,635,898
Stock-based interest compensation to convertible notes holders			1,214,943
Issuance costs allocated to warrants with down-round protection	40,555	390,928	431,483
Change in the fair value of warrants issued with round down protection	(6,384,895)	(141,357)	(169,545)
Linkage difference on principal of loans from stockholders	666	14,903	201,946
Interest on convertible notes			78,192
Gain on sale of property and equipment			(912)
Gain from trading marketable securities			(12,920)
Changes in assets and liabilities:
Increase in accounts receivable	(14,319)		(14,319)
Increase in inventory	(139,308)		(139,308)
Decrease (increase) in other current assets	(16,354)	16,111	(91,006)
Increase in accounts payable	151,892	70,476	196,625
Increase (decrease) in other current liabilities	140,541	(52,568)	374,184
Net cash used in operating activities	(2,419,839)	(2,282,455)	(17,211,666)
Cash flows from investment activities:
Increase in funds in respect of employee rights upon retirement	(28,058)	(39,923)	(177,279)
Purchase of property and equipment	(51,485)	(51,777)	(335,857)
Proceeds from sale of property and equipment			4,791
Investment in marketable securities			(388,732)
Proceeds from sale of marketable securities			406,995
Short-term loan granted to related party, net of repayments			(14,252)
Net cash used in investment activities	(79,543)	(91,700)	(504,334)
Cash flows from financing activities
Credit from banking institutions (repayment)		(38,458)	(8,671)
Proceeds from issuance of convertible notes			1,144,000
Repayment of convertible notes			(527,396)
Proceeds from issuance of Common Stock, net of cash issuance expenses			11,323,559
Cash dividend to Preferred Stock holders	(277,852)	(102,819)	(566,100)
Proceeds allocated to convertible Preferred Stock, net of cash issuance expenses	2,435,844	3,960,958	6,396,802
Proceeds from stockholders loans			347,742
Net cash provided by financing activities	4,542,421	5,241,664	21,916,348
Effect of exchange rate changes on cash and cash equivalents	(40,970)	105,695	187,632
Increase in cash and cash equivalents	2,002,069	2,973,204	4,387,980
Cash and cash equivalents at beginning of the period	2,385,911	543,411
Cash and cash equivalents at end of the period	4,387,980	3,516,615	4,387,980
Warrants with Down-Round Protection [Member]
Cash flows from financing activities
Proceeds allocated to warrants, net of issuance expenses		1,421,983	1,421,983
Series B-1 and Series B-2 Warrants [Member]
Cash flows from financing activities
Proceeds allocated to warrants, net of issuance expenses	$ 2,384,429		$ 2,384,429